Search Results - "van Hennik, M B"

Malignant Leydig cell tumor of the testis in complete remission on o,p'-dichlorodiphenyl-dichloroethane by van der Hem, K G, Boven, E, van Hennik, M B, Pinedo, H M

“…A 56-year-old patient is described who presented with retroperitoneal lymph node metastases 2 years after resection of a Leydig cell tumor of the left testis…”
Get more information

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma by Willemze, R, Peters, W G, van Hennik, M B, Fibbe, W E, Kootte, A M, van Berkel, M, Lie, R, Rodenburg, C J, Veltkamp, J J

“…27 patients (aged 15-55 years) with relapsed acute myelogenous (AML) and lymphoblastic leukaemia (ALL), and with lymphoblastic non Hodgkin's lymphoma (NHL)…”
Get more information

Comparative pharmacokinetics of cisplatin and three analogues in mice and humans by VAN HENNIK, M. B, VAN DER VIJGH, W. J. F, KLEIN, I, ELFERINK, F, VERMORKEN, J. B, WINOGRAD, B, PINEDO, H. M

“…Pharmacokinetics of cisplatin, spiroplatin, ethylenediaminemalonatoplatinum(II) (JM-40), and carboplatin was studied in BALB/c x DBA/2 F1 mice receiving 10%…”
Get full text

Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study by Schwartsmann, G, van der Vijgh, W J, van Hennik, M B, Klein, I, Vermorken, J B, Dodion, P, ten Bokkel Huinink, W W, Joggi, G, Gall, H, Crespeigne, N

“…The pharmacokinetics of the novel antipyrimidine agent Brequinar sodium (NSC 368390; DUP 785) was studied in 23 patients with solid tumors during the phase I…”
Get more information

Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies by SCHWARTSMANN, G, DODION, P, CRESPEIGNE, N, PINEDO, H. M, VERMORKEN, J. B, TEN BOKKEL HUININK, W. W, JOGGI, J, WINOGRAD, B, GALL, H, SIMONETTI, G, VAN DER VIJGH, W. J. F, VAN HENNIK, M. B

“…Brequinar sodium (DUP 785, NSC 368390) is a novel quinoline-carboxylic acid derivative that has been selected for clinical evaluation because of its broad…”
Get full text

Human pharmacokinetics of carboplatin after oral administration by VAN HENNIK, M. B, VAN DER VIJGH, W. J. F, KLEIN, I, VERMORKEN, J. B, PINEDO, H. M

Get full text

Arteriovenous malformations as a cause for recurrent or chronic blood loss from the digestive tract by de Graaf, P W, Mulder, H, Runsink, A P, van Hennik, M B

Get more information